Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity
Rosiglitazone in the treatment of weight gain and metabolic dysfunction during olanzapine administration: a double-blind, placebo controlled pilot study
Baptista TSociety of Neuroscience Annual Meeting[2007]
Review of limited systemic absorption of orlistat, a lipase inhibitor, in healthy human volunteers
Metformin as an adjunctive treatment to control body weight and metabolic dysfunction during olanzapine administration: a multicentric, double-blind, placebo-controlled trial
Metformin addition attenuates olanzapine-induced weight gain in drug-naive first episode schizophrenia patients: a double blind placebo-controlled study
Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo
Effect of naltrexone plus bupropion on weight loss in overweight and obese adults(COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial
A randomized, double-blind, placebo-controlled trial of metformin in treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents